First Trust NYSE Arca Biotechnology Index Fund Stock Forecast, Price & News

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Frequently Asked Questions

What stocks does MarketBeat like better than First Trust NYSE Arca Biotechnology Index Fund?

Wall Street analysts have given First Trust NYSE Arca Biotechnology Index Fund a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but First Trust NYSE Arca Biotechnology Index Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has First Trust NYSE Arca Biotechnology Index Fund's stock been impacted by COVID-19?

First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $131.15 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FBT stock has increased by 24.9% and is now trading at $163.82.
View which stocks have been most impacted by COVID-19.

What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), The Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY).

What is First Trust NYSE Arca Biotechnology Index Fund's stock symbol?

First Trust NYSE Arca Biotechnology Index Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FBT."

Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders?

First Trust NYSE Arca Biotechnology Index Fund's stock is owned by a number of institutional and retail investors. Top institutional investors include McGuire Investment Group LLC (0.29%), Private Advisor Group LLC (0.26%), Kestra Advisory Services LLC (0.21%), Crumly & Associates Inc. (0.17%), Spectrum Wealth Advisory Group LLC (0.14%) and Kestra Private Wealth Services LLC (0.14%).

Which major investors are selling First Trust NYSE Arca Biotechnology Index Fund stock?

FBT stock was sold by a variety of institutional investors in the last quarter, including Kestra Advisory Services LLC, Avantax Advisory Services Inc., Private Advisor Group LLC, IFP Advisors Inc, Crumly & Associates Inc., NEXT Financial Group Inc, Cambridge Advisors Inc., and Great Valley Advisor Group Inc..

Which major investors are buying First Trust NYSE Arca Biotechnology Index Fund stock?

FBT stock was acquired by a variety of institutional investors in the last quarter, including HBW Advisory Services LLC, Koshinski Asset Management Inc., Juncture Wealth Strategies LLC, TPG Financial Advisors LLC, RFG Advisory LLC, McGuire Investment Group LLC, Total Clarity Wealth Management Inc., and Guidance Point Advisors LLC.

How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund?

Shares of FBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is First Trust NYSE Arca Biotechnology Index Fund's stock price today?

One share of FBT stock can currently be purchased for approximately $163.82.

How much money does First Trust NYSE Arca Biotechnology Index Fund make?

First Trust NYSE Arca Biotechnology Index Fund has a market capitalization of $1.79 billion.